Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 14 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Relay Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- −12 vs. Q1 2021
- Shares held
- 89.1M
- +3.55M (+4.1%) vs. Q1 2021
- Total value
- $3.26B
- +$301.6M (+10.2%) vs. Q1 2021
- New holders
- 11
- 62 more added
- Sold out
- 23
- 22 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RLAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 259 | $4.58B |
| Q1 2026 | 244 | $1.83B |
| Q4 2025 | 227 | $1.47B |
| Q3 2025 | 199 | $867.4M |
| Q2 2025 | 208 | $591.8M |
| Q1 2025 | 208 | $438.1M |
| Q4 2024 | 200 | $675.8M |
| Q3 2024 | 195 | $1.16B |
| Q2 2024 | 179 | $826.8M |
| Q1 2024 | 189 | $1.10B |
| Q4 2023 | 177 | $1.40B |
| Q3 2023 | 172 | $1.10B |
| Q2 2023 | 161 | $1.64B |
| Q1 2023 | 157 | $2.16B |
| Q4 2022 | 165 | $1.91B |
| Q3 2022 | 162 | $2.76B |
| Q2 2022 | 148 | $2.02B |
| Q1 2022 | 140 | $3.38B |
| Q4 2021 | 131 | $3.41B |
| Q3 2021 | 132 | $2.89B |
| Q2 2021 | 125 | $3.26B |
| Q1 2021 | 137 | $2.96B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Relay Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harvard Management Co Inc | 541,124 | $19.8M | 1.14% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 556,380 | $20.4M | 2.75% | −1,583,000−74.0% | Reduced |
| Candriam Luxembourg S.C.A. | 562,938 | $20.6M | 0.14% | +562,927+5,117,518.2% | Added |
| Morgan Stanley | 569,645 | $20.8M | 0.00% | +79,037+16.1% | Added |
| Bessemer Group Inc | 584,463 | $21.4M | 0.05% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 600,000 | $22.0M | 0.04% | −218,309−26.7% | Reduced |
| Geode Capital Management, LLC | 707,895 | $25.9M | 0.00% | +103,962+17.2% | Added |
| Gilder Gagnon Howe & Co LLC | 835,538 | $30.6M | 0.15% | −1,184,923−58.6% | Reduced |
| Price T Rowe Associates Inc | 1,173,482 | $42.9M | 0.00% | −331,610−22.0% | Reduced |
| Alliancebernstein L.P. | 1,244,765 | $45.5M | 0.02% | +191,474+18.2% | Added |
| Wellington Management Group LLP | 1,268,187 | $46.4M | 0.01% | +423,083+50.1% | Added |
| Boxer Capital, LLC | 1,294,132 | $47.4M | 1.67% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,423,327 | $52.1M | 0.01% | +43,821+3.2% | Added |
| Alphabet Inc. | 1,826,876 | $66.8M | 1.36% | +258,390+16.5% | Added |
| Perceptive Advisors LLC | 2,018,097 | $73.8M | 0.96% | 00.0% | Unchanged |
| State Street Corp | 2,218,160 | $81.2M | 0.00% | +202,584+10.1% | Added |
| Bellevue Group AG | 2,640,962 | $96.6M | 0.94% | +709,618+36.7% | Added |
| Driehaus Capital Management LLC | 2,854,040 | $104.4M | 1.38% | +311,421+12.2% | Added |
| BVF Inc | 2,938,202 | $107.5M | 4.03% | +65,055+2.3% | Added |
| Casdin Capital, LLC | 3,375,058 | $123.5M | 3.13% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,293,442 | $157.1M | 0.00% | +242,361+6.0% | Added |
| EcoR1 Capital, LLC | 4,487,776 | $164.2M | 6.16% | +1,058,413+30.9% | Added |
| BlackRock Inc. | 4,540,330 | $166.1M | 0.00% | +741,600+19.5% | Added |
| FMR LLC | 10,362,000 | $379.1M | 0.03% | +4,533,548+77.8% | Added |
| SB Investment Advisers (UK) Ltd | 27,904,963 | $1.02B | 2.00% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Mission Creek Capital Partners, Inc. | 0 | $0 | 0.00% | −296,802−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −193,703−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −101,111−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −65,790−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −30,134−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −22,958−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −18,593−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −17,778−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −11,548−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −9,014−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −8,482−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −6,929−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −6,310−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −2,166−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,981−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,869−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,767−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −979−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −202−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −18−100.0% | Sold out |